EGFR and neoplasm: Gains of oncogenes including EGFR (7p12), ERBB2 (17q12), KRAS in the EGFR pathway were characteristic for LUAD and contribute to cell proliferation and tumor development, suggesting this is a core requirement for LUAD pathogenesis.